Literature DB >> 11673463

Proteolytic sensitivity and helper T-cell epitope immunodominance associated with the mobile loop in Hsp10s.

Stephanie Carmicle1, Guixiang Dai, N Kalaya Steede, Samuel J Landry.   

Abstract

Antigen three-dimensional structure potentially limits antigen processing and presentation to helper T-cell epitopes. The association of helper T-cell epitopes with the mobile loop in Hsp10s from mycobacteria and bacteriophage T4 suggests that the mobile loop facilitates proteolytic processing and presentation of adjacent sequences. Sites of initial proteolytic cleavage were mapped in divergent Hsp10s after treatment with a variety of proteases including cathepsin S. Each protease preferentially cleaved the Hsp10s in the mobile loop. Flexibility in the 22-residue mobile loop most probably allows it to conform to protease active sites. Three variants of the bacteriophage T4 Hsp10 were constructed with deletions in the mobile loop to test the hypothesis that shorter loops would be less sensitive to proteolysis. The two largest deletions effectively inhibited proteolysis by several proteases. Circular dichroism spectra and chemical cross-linking of the deletion variants indicate that the secondary and quaternary structures of the variants are native-like, and all three variants were more thermostable than the wild-type Hsp10. Local structural flexibility appears to be a general requirement for proteolytic sensitivity, and thus, it could be an important factor in antigen processing and helper T-cell epitope immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673463     DOI: 10.1074/jbc.M107624200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin.

Authors:  Samuel J Landry
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

3.  Healthy individuals have Goodpasture autoantigen-reactive T cells.

Authors:  Juan Zou; Sigrid Hannier; Lindsay S Cairns; Robert N Barker; Andrew J Rees; A Neil Turner; Richard G Phelps
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

4.  Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.

Authors:  Hong-Nam P Nguyen; N Kalaya Steede; James E Robinson; Samuel J Landry
Journal:  Vaccine       Date:  2015-05-02       Impact factor: 3.641

5.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120.

Authors:  Denise Mirano-Bascos; N Kalaya Steede; James E Robinson; Samuel J Landry
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

7.  Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.

Authors:  Sepideh Afshar; Tsuneaki Asai; Sherie L Morrison
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

8.  Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes.

Authors:  Daniel L Moss; Hee-Won Park; Ramgopal R Mettu; Samuel J Landry
Journal:  J Biol Chem       Date:  2019-01-25       Impact factor: 5.157

9.  Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120.

Authors:  Denise Mirano-Bascos; Magdalena Tary-Lehmann; Samuel J Landry
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

10.  Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT.

Authors:  Sepideh Afshar; Tove Olafsen; Anna M Wu; Sherie L Morrison
Journal:  J Exp Clin Cancer Res       Date:  2009-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.